Stem Cell Discovery

Volume 11, Issue 1 (January 2021)

ISSN Print: 2161-6760   ISSN Online: 2161-6787

Google-based Impact Factor: 1.33  Citations  

Isolation and Ex Vivo Expansion of Human Hematopoietic Stem Cells Derived from Umbilical Cord Blood

HTML  XML Download Download as PDF (Size: 539KB)  PP. 1-13  
DOI: 10.4236/scd.2021.111001    771 Downloads   2,741 Views  Citations

ABSTRACT

Umbilical cord blood (UCB) is a current major source of hematopoietic stem cells (HSCs) for cell transplantation therapy. Cell transplantation with HSCs derived from UCB is advantageous over transplantation with HSCs from adult tissues. However, the low number of HSC derived from a single unit of UCB limits its application. Thus, ex vivo expansion is a good option to create more UCB HSCs for clinical application. The strategies for HSC expansion in vitro focus on mimicking the composition and structure of HSC natural niche by enhancing self-renewal and inhibiting lineage differentiation of HSCs. In the past decade, the mechanisms of the interaction between HSC and the natural niche have been deeply investigated. This great progress in basic research has led to advancements in UCB HSC ex vivo expansion. In addition, the biological characteristics of the originally isolated UCB HSCs correlate with outcome of subsequent ex vivo expansion. In this paper, we summarize the late progress achieved in isolation and ex vivo expansion of UCB HSCs. Importantly, we attempt to provide an impact and practicable procedure to expand UCB HSC in vitro from isolation of original HSCs to identification of expanded HSCs.

Share and Cite:

Pang, M. , Han, S. , Ren, M. , Guan, D. , Kuang, T. , Liu, S. , Liu, Y. , Chen, J. , Wang, F. , Shi, C. and Ye, Z. (2021) Isolation and Ex Vivo Expansion of Human Hematopoietic Stem Cells Derived from Umbilical Cord Blood. Stem Cell Discovery, 11, 1-13. doi: 10.4236/scd.2021.111001.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.